Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Muscle disorders
ADR ID BADD_A02879
ADR Hierarchy
15      Musculoskeletal and connective tissue disorders
15.05      Muscle disorders
Description Acquired, familial, and congenital disorders of SKELETAL MUSCLE and SMOOTH MUSCLE. [MeSH]
MedDRA Code 10028302
MeSH ID D009135
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Muscular Diseases | Muscular Disease | Myopathies | Myopathy | Muscle Disorders | Muscle Disorder | Myopathic Conditions | Myopathic Condition
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00254Bepridil--
BADD_D00260Betamethasone--
BADD_D00263Betaxolol--
BADD_D00264Betaxolol hydrochloride--
BADD_D00265Bethanechol--
BADD_D00267Betiatide--
BADD_D00268Bevacizumab--
BADD_D00269Bexarotene0.000806%
BADD_D00270Bezafibrate--
BADD_D00271Bicalutamide0.010545%
BADD_D00274Bimatoprost--
BADD_D00276Bisacodyl--
BADD_D00277Bisoprolol0.007347%
BADD_D00278Bisoprolol fumarate--
BADD_D00279Bivalirudin--
BADD_D00280Bleomycin--
BADD_D00281Bleomycin sulfate--
BADD_D00282Blinatumomab--
BADD_D00283Boceprevir--
BADD_D00284Bortezomib0.000168%
BADD_D00285Bosentan0.000361%
BADD_D00286Bosutinib0.009021%
BADD_D00287Bosutinib monohydrate--
BADD_D00289Botulinum neurotoxin a/b immune globulin (human)--
BADD_D00290Botulinum toxin type a--
BADD_D00291Brentuximab vedotin--
BADD_D00293Brexpiprazole0.007801%
BADD_D00294Brimonidine0.000380%
BADD_D00295Brimonidine tartrate--
BADD_D00296Brinzolamide0.001169%
The 6th Page    First    Pre   6 7 8 9 10    Next   Last    Total 56 Pages